Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Postmenopausal Osteoporosis Market, by Region, 2020-2028 (USD Million)
1.2.2. Postmenopausal Osteoporosis Market, by Treatment, 2020-2028 (USD Million)
1.2.3. Postmenopausal Osteoporosis Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Postmenopausal Osteoporosis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Postmenopausal Osteoporosis Market Dynamics
3.1. Postmenopausal Osteoporosis Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Investment by Market Players and Thereby Strong Pipeline
3.1.1.2. Increase in Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Low Awareness of Postmenopausal Osteoporosis
3.1.3. Market Opportunities
3.1.3.1. New Product Launches
3.1.3.2. Increase in Clinical Trails for better diagnostic solutions
Chapter 4. Global Postmenopausal Osteoporosis Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Postmenopausal Osteoporosis Market, by Treatment
6.1. Market Snapshot
6.2. Global Postmenopausal Osteoporosis Market by Treatment, Performance - Potential Analysis
6.3. Global Postmenopausal Osteoporosis Market Estimates & Forecasts by Treatment, 2018-2028 (USD Million)
6.4. Postmenopausal Osteoporosis Market, Sub Segment Analysis
6.4.1. Vitamin D
6.4.2. Bisphosphonates
6.4.3. Hormone Replacement Therapy
6.4.4. Parathyroid Hormone Therapy
6.4.5. Others
Chapter 7. Global Postmenopausal Osteoporosis Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Postmenopausal Osteoporosis Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Postmenopausal Osteoporosis Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Million)
7.4. Postmenopausal Osteoporosis Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Postmenopausal Osteoporosis Market, Regional Analysis
8.1. Postmenopausal Osteoporosis Market, Regional Market Snapshot
8.2. North America Postmenopausal Osteoporosis Market
8.2.1. U.S. Postmenopausal Osteoporosis Market
8.2.1.1. Treatment breakdown estimates & forecasts, 2018-2028
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Postmenopausal Osteoporosis Market
8.3. Europe Postmenopausal Osteoporosis Market Snapshot
8.3.1. U.K. Postmenopausal Osteoporosis Market
8.3.2. Germany Postmenopausal Osteoporosis Market
8.3.3. France Postmenopausal Osteoporosis Market
8.3.4. Spain Postmenopausal Osteoporosis Market
8.3.5. Italy Postmenopausal Osteoporosis Market
8.3.6. Rest of Europe Postmenopausal Osteoporosis Market
8.4. Asia-Pacific Postmenopausal Osteoporosis Market Snapshot
8.4.1. China Postmenopausal Osteoporosis Market
8.4.2. India Postmenopausal Osteoporosis Market
8.4.3. Japan Postmenopausal Osteoporosis Market
8.4.4. Australia Postmenopausal Osteoporosis Market
8.4.5. South Korea Postmenopausal Osteoporosis Market
8.4.6. Rest of Asia Pacific Postmenopausal Osteoporosis Market
8.5. Latin America Postmenopausal Osteoporosis Market Snapshot
8.5.1. Brazil Postmenopausal Osteoporosis Market
8.5.2. Mexico Postmenopausal Osteoporosis Market
8.6. Rest of The World Postmenopausal Osteoporosis Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Ligand Pharmaceuticals Incorporated
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Amgen Inc.
9.2.3. Novartis International AG
9.2.4. Merck & Co., Inc
9.2.5. Proctor & Gamble Co.
9.2.6. Eli Lilly and CO.
9.2.7. Enteris BioPharma
9.2.8. Pfizer Inc
9.2.9. Oncobiologics, Inc.
9.2.10. Clonz Biotech
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption